• Legal Notice – MuscleMecca Forums

    MuscleMecca.com is an educational discussion platform. We do not sell, promote, or endorse any bodybuilding gear, supplements, research chemicals, or performance-enhancing substances.

    All discussions are for educational and informational purposes only. Nothing posted on this forum should be considered medical or legal advice.

    Do not attempt to sell, source, or promote illegal substances. Any such activity will result in an immediate and permanent ban and may be reported to the proper authorities.

    By using this site, you agree to comply with all forum rules, disclaimers, and applicable laws in your jurisdiction.

    Read Our Full Disclaimer and Forum Rules

Gran Fondo New York Gives Lifetime Ban to Two Amateur Cyclists for EPO

RoidVisor.com

RoidVisor.com

Mecca V.I.P.
VIP
Member
Joined
Dec 14, 2018
Messages
154
Points
18
Gran Fondo New York Gives Lifetime Ban to Two Amateur Cyclists for EPO
Cycle 1
 
Last edited by a moderator:
MuscleMecca Crew

MuscleMecca Crew

MuscleMecca Crew
Staff
Author
Joined
May 11, 2012
Messages
4,317
Points
83
Two South American cyclists tested positive for a banned blood boosting drug.
Amateur cyclists Gabriel Raff (Argentina) and Felipe Mendez (Colombia) were given lifetime suspensions by the Gran Fondo New York organization. Both cyclists tested positive for recombinant erythropoietin (EPO) during out-of-competition drug tests administered prior to the GFNY World Championship in New York City on May 19, 2019.
Raff and Mendez are prohibited from competing at any GFNY in the future. GFNY events are held around the world with competitions in the United States, Mexico, Argentina, Brazil, Indonesia, Chile, Colombi, Portugal, Italy, Israel and several other locations.
The lifetime ban only applies to GFNY events. Sports federations and organizations that have adopted World Anti-Doping Agency (WADA) rules will also recognize the anti-doping violation. But Raff and Mendez will likely only face a limited period of ineligibility of four years or less in those competitions.

GFNY drug testing targets athletes most likely to win.

Raff and Mendez were supposedly randomly selected for anti-doping controls. But they were actually targeted in a pool of 60 participants who were considered most likely to win their age group and/or place in the top ten.
The GFNY Global Cycling Marathon Series is one of the few amateur events that routinely tests competitors for prohibited performance-enhancing drugs (PEDs). The anti-doping controls also include out-of-competition testing.
Uli Fluhme, the chief executive officer of GFNY, believes that doping is just as serious a violation as course cutting. While this is debatable, GFNY has treated doping as a very serious problem.
“We don’t allow course cutting at our races so why would we look the other way when it comes to doping?” asked Fluhme.
GFNY has administered anti-doping controls since 2012. GFNY estimated that it spends well over $15,000 per year on drug testing.
Seven athletes have received lifetime suspensions from GFNY events including Raff and Mendez. Age-group winners David Anthony and Gabriele Guarini tested positive for EPO in 2012. Overall winer Oscar Tovar and third-place women’s finisherYamile Lugo both tested positive for the anabolic steroid testosterone in 2015. And Manuel Serrano Plowells tested positive for EPO in 2017.
GFNY takes an extremely hard stance against anti-doping. In addition to issuing lifetime bans to anti-doping rule violators, GFNY requires that dopers pay additional financial penalties.
Banned athletes are required to reimburse GFNY for the costs of the anti-doping tests. And they are also required to financially compensate GFNY for any reputational damage that results from the negative publicity.
It seems unlikely that any athletes with a lifetime suspension would bother to fulfill those financial penalties.
 

Similar threads

Maxmonzter
Replies
0
Views
2K
Maxmonzter
Maxmonzter
Zem_Fitness
Replies
1
Views
258
NPCNewsOnline
NPCNewsOnline
LiftWithPurpose
Replies
0
Views
615
LiftWithPurpose
LiftWithPurpose
Top